Logo
Logo

About Levofloxacin Hemihydrate API

Product
  • Therapeutic CategoryAnti-Infeccioso

  • API Technology

    Synthetic

  • Dose Form

    Injectable, Solution/Tablet

  • Dr Reddy's Development Status

    Available (Commercial)

  • Available Regulatory Filing

    USDMF, CEP Submitted, Brazil DMF, EUDMF, Korea DMF, Russia DMF

Mecanismo de acción

Levofloxacin inhibits bacterial type II topoisomerases, topoisomerase IV and DNA gyrase. Levofloxacin, like other fluoroquinolones, inhibits the A subunits of DNA gyrase, two subunits encoded by the gyrA gene. This results in strand breakage on a bacterial chromosome, supercoiling, and resealing; DNA replication and transcription is inhibited.

Indicación

LEVAQUIN® is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated. 

  • Pneumonia: Nosocomial and Community Acquired
  • Skin and Skin Structure Infections (SSSI): Complicated and Uncomplicated
  • Chronic bacterial prostatitis
  • Inhalational Anthrax, Post-Exposure in adult and pediatric patients
  • Plague in adult and pediatric patients
  • Urinary Tract Infections (UTI): Complicated and Uncomplicated
  • Acute Pyelonephritis
  • Acute Bacterial Exacerbation of Chronic Bronchitis
  • Acute Bacterial Sinusitis

Usage:

To reduce the development of drug-resistant bacteria and maintain the effectiveness of LEVAQUIN® and other antibacterial drugs, LEVAQUIN® should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria IQUIX® solution is a topical quinolone antimicrobial indicated for the treatment of corneal ulcer caused by susceptible strains of the following bacteria: 

  • Corynebacterium species*
  • Staphylococcus aureus
  • Staphylococcus epidermidis
  • Streptococcus pneumonia
  • Viridans group streptococci*
  • Pseudomonas aeruginosa
  • Serratia marcescens*

Experiencia de Dr. Reddy

Con sede en Hyderabad, India, Dr. Reddy's Laboratories es uno de los principales proveedores de ingredientes farmacéuticos activos (API) a nivel mundial. El negocio API de Dr. Reddy es considerado como un socio preferido de las compañías farmacéuticas en los Estados Unidos, Europa, Brasil, América Latina, Japón, China, Corea y los mercados emergentes.

El negocio de API de Dr. Reddy se nutre de las fortalezas técnicas profundas establecidas en los últimos 30 años en el desarrollo y fabricación de API complejas como esteroides, péptidos, moléculas complejas de cadena larga y API altamente potentes (HPAPI / medicamentos oncológicos). Esta experiencia se complementa con nuestra destreza en propiedad intelectual y asuntos regulatorios que nos ayudan a cumplir y superar los estándares regulatorios de manera consistente. Los APIs de Dr. Reddy´s Levofloxacina Hemihidrato es el resultado de la amplia experiencia en R&D, IP y Normatividad Aplicable.

Un componente clave para ayudar a nuestros clientes a ser los primeros en comercializar es una cadena de suministro receptiva. Logramos esto al asegurarnos de que todas nuestras instalaciones funcionen de manera eficiente y con los últimos estándares de calidad, seguridad y productividad. Una fuerte interconexión entre las empresas y las fábricas permite una reacción rápida a los cambios dinámicos del mercado, de modo que podamos evitar la escasez y satisfacer los repentinos aumentos de la demanda.

RFQ Form

Phone

Related Resources

Description not provided

FAQs

What drug class is Levofloxacin Hemihydrate API ?
  • Levofloxacin belongs to the class of medicines known as quinolone antibiotics. It is a third-generation fluoroquinolone antibiotic and optically active L-isomer of ofloxacin with antibacterial activity.

What is main purpose of using the Levofloxacin Hemihydrate API ?
  • Treatment of Acute Bacterial Sinusitis and Acute Exacerbation of Chronic Bronchitis when these infections have been adequately diagnosed.

What is the safety guide for Levofloxacin Hemihydrate API ?
  • Pneumonia - 500 mg orally or IV every 24 hours for 7 to 14 days. Prostatitis- 500 mg orally or IV every 24 hours for 28 days.

What are Dr.Reddy's Offerings for Levofloxacin Hemihydrate API ?
  • We offer Crystalline Form

What is the process available for ordering Levofloxacin Hemihydrate API ?
Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.